The main ongoing studies: REDEFINE 1 , Phase 3 obesity without T2D (results 20242025, preliminarily 25.3 %) REDEFINE 2 , Phase 3 obesity + T2D REDEFINE 3 , Phase 3 cardiovascular outcome trial (n~7000) Stand-alone clinical development of Cagrilintide is limited , Novo Nordisk is primarily investing in the CagriSema combination
It targets adipose tissue, promoting weight loss without affecting insulin or blood sugar levels
Escalation phase breakdown The standard protocol starts low and increases every four weeks to minimize gastrointestinal side effects that rapid dose escalation can cause
Book appointment online To receive further guidance on vitamin B12 injections, please book an appointment online with our experienced team at Chatham Pharmacy
For details, see our Protein Powders Review , which includes our Top Picks for protein powders and shakes